The effect of levodopa–carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson’s disease: a multicenter Romanian experience
Chronic treatment with oral levodopa is associated with an increased frequency of motor complications in the late stages of Parkinson’s disease (PD). Continuous administration of levodopa–carbidopa intestinal gel (LCIG—Duodopa®, Abbott Laboratories), which has been available in Romania since 2009, r...
Main Authors: | Băjenaru, O., Ene, A., Popescu, B. O., Szász, J. A., Sabău, M., Mureşan, D. F., Perju-Dumbrava, L., Popescu, C. D., Constantinescu, A., Buraga, I., Simu, M. |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer Vienna
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805768/ |
Similar Items
-
Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets
by: Othman, Ahmed A, et al.
Published: (2014) -
Comparison of the pharmacokinetics of an oral extended‐release capsule formulation of carbidopa‐levodopa (IPX066) with immediate‐release carbidopa‐levodopa (Sinemet®), sustained‐release carbidopa‐levodopa (Sinemet® CR), and carbidopa‐levodopa‐entacapone (Stalevo®)
by: Hsu, Ann, et al.
Published: (2015) -
Effect of levodopa‐carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients
by: Antonini, Angelo, et al.
Published: (2016) -
Integrated safety of levodopa‐carbidopa intestinal gel from prospective clinical trials
by: Lang, Anthony E., et al.
Published: (2015) -
Jejunal Infusion of Levodopa–Carbidopa Intestinal Gel Versus Oral Administration of Levodopa–Carbidopa Tablets in Japanese Subjects with Advanced Parkinson’s Disease: Pharmacokinetics and Pilot Efficacy and Safety
by: Othman, Ahmed A., et al.
Published: (2015)